Lung Cancer
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
News
USPSTF expands criteria for lung cancer screening
The population now eligible for lung cancer screening has more than doubled.
News
FDA approves cemiplimab-rwlc for NSCLC with PD-L1 expression
This approval “means physicians and patients have a potent new treatment option against this deadly disease.”
Article
How has the pandemic affected rural and urban cancer patients?
News
FDA approves first drug that protects against chemo-induced myelosuppression
Conference Coverage
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLC
Conference Coverage
Model could reduce some disparities in lung cancer screening
Conference Coverage
Customized chemotherapy did not improve survival in early NSCLC
Toxicity was less common with customized therapy.
Conference Coverage
Neoadjuvant atezolizumab safe for patients with resectable lung cancer
Neoadjuvant atezolizumab was deemed “effective, well tolerated, and surgically acceptable.”
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
